Preferred Partners
We recognise that as a small but expanding company we cannot provide all of the preclinical services in our three disease fields. Our clients however need a broad range of services to ensure a comprehensive evaluation of their compounds. We have established preferred partner contracts with a number of groups recognised to be leaders in fields such as:
- COPD (three test models reflecting airway inflammation, virus induced exacerbations and emphysema)
- Emesis
- Lung Fibrosis
- Human tissue/cell tests.
Our contractual arrangement with these partners ensures the same standards as we offer in-house, with confidentiality, client IP ownership and high interactivity being uppermost.
Each of our partners is a leader in their field and has established tests/models, which are reliable, robust and validated as is expected of any preclinical research service company. As with Pneumolabs our partners also offer consultancy, study plans, in-depth data analysis, a final report and strategic advice if required. Deadlines are rapid but always realistic.
Finally our partners are flexible in the services they offer such as additional end points ie. cardiovascular effects, skeletal muscle changes etc to name a few.